Jostein Davidsen
Director/Board Member bei NAVAMEDIC ASA
Profil
Jostein Davidsen is currently a Director at Navamedic ASA, Labatec Pharma SA, Sensidose AB, Primex Pharmaceuticals Oy, and Primex Pharmaceuticals AG.
He previously served as the Chief Executive Officer at Acino International AG and as a Corporate Officer and Head of Emerging Markets at Takeda Pharmaceutical Co., Ltd.
and Takeda A from 2011 to 2014.
Aktive Positionen von Jostein Davidsen
Unternehmen | Position | Beginn |
---|---|---|
NAVAMEDIC ASA | Director/Board Member | 16.01.2017 |
SENSIDOSE AB | Director/Board Member | - |
Primex Pharmaceuticals Oy
Primex Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals Oy manufactures and markets healthcare products. The fims's products include Dobuject and Recofol N. It also produces several other products for anesthesia and intensive care. The company was founded by Mikko Laiho, Pekka Leinonen, Janne Kovalainen, Kari Sarvanto and Jany Mengelkamp in 2008 and is headquartered in Helsinki, Finland. | Director/Board Member | 03.05.2017 |
Labatec Pharma SA
Labatec Pharma SA Pharmaceuticals: MajorHealth Technology Labatec Pharma SA engages in the provision of pharmaceutical business. Its products include injectable and orals for hospital use, specialty retail prescription, and over-the-counter products and supplements. The company was founded in 1957 and is headquartered in. | Director/Board Member | - |
Primex Pharmaceuticals AG
Primex Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals AG operates as a pharmaceutical company which develops, manufactures, and markets healthcare products and medicines to consumers and healthcare professionals. The company was founded by Kari Sarvanto in 2008 and is headquartered in Zug, Switzerland. | Director/Board Member | 01.01.2017 |
Ehemalige bekannte Positionen von Jostein Davidsen
Unternehmen | Position | Ende |
---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Corporate Officer/Principal | 01.01.2014 |
ACINO HOLDING AG | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
NAVAMEDIC ASA | Distribution Services |
SENSIDOSE AB | Electronic Technology |
Private Unternehmen | 5 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
Labatec Pharma SA
Labatec Pharma SA Pharmaceuticals: MajorHealth Technology Labatec Pharma SA engages in the provision of pharmaceutical business. Its products include injectable and orals for hospital use, specialty retail prescription, and over-the-counter products and supplements. The company was founded in 1957 and is headquartered in. | Health Technology |
Primex Pharmaceuticals Oy
Primex Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals Oy manufactures and markets healthcare products. The fims's products include Dobuject and Recofol N. It also produces several other products for anesthesia and intensive care. The company was founded by Mikko Laiho, Pekka Leinonen, Janne Kovalainen, Kari Sarvanto and Jany Mengelkamp in 2008 and is headquartered in Helsinki, Finland. | Health Technology |
Primex Pharmaceuticals AG
Primex Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals AG operates as a pharmaceutical company which develops, manufactures, and markets healthcare products and medicines to consumers and healthcare professionals. The company was founded by Kari Sarvanto in 2008 and is headquartered in Zug, Switzerland. | Health Technology |